Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jim Simons Bets Big on Apple Inc. (APPL), Intel Corporation (INTC) and Verizon Communications Inc. (VZ)

I have dreamt more than once, like many others, about having access to Jim Simons’ investment formula, to his extremely complex mathematical models. As this is not an actual option, tracking his moves might be the second-best alternative. So, in this article, I will take a look at some of Renaissance Technologies’ most important moves over Q1 2014 (declared in the recently filed Form 13F).

As it is usual amongst major funds, Renaissance Technologies’ focus on technology and services stocks continued through the first quarter. These two segments account for half of its portfolio’s value. One of the fund’s largest bets was recently placed on Apple Inc. (NASDAQ:AAPL), a $505 billion market cap computer and devices maker that needs no introduction whatsoever. Over the first fiscal quarter, Simons started a position with 821,362 shares, worth more than $440 million. This holding accounts for approximately 1% of the fund’s equity portfolio, and stands as its eighth most valuable one.

RENAISSANCE TECHNOLOGIES

However, a few funds hold even larger stakes at the tech company. For instance, Carl Icahn’s Icahn Capital Lp, upped its wager on the company by 59% over Q1, and now owns more than $4 billion in stock.

Simons’ bets on tech do not stop at Apple. Another tech about which this guru seems to feel confident is Intel Corporation (NASDAQ:INTC), a $128 billion market cap semiconductor chip maker that develops integrated digital technology products. Over Q1, Renaissance Technologies increased its position in the stock by 23%, and now owns about 14 million shares, worth more than $360 million.

However, Simons’ bet is smaller when compared to Harris Associates’ 66.857 million shares, worth about $1.725 billion, or Jean-Marie Eveillard’s First Eagle Investment Management’s 38 million shares, up 8% in relation to Q4 2013. I should also mention that Clint Carlson’s Carlson Capital also started, over Q1, a position in the stock, worth more than $100 million.

Finally, within the services segment, there’s Verizon Communications Inc. (NYSE:VZ), a $203 billion market cap provider of communications, information and entertainment products and services in which Simons has almost half a billion dollars invested. Over the first fiscal quarter, his fund increased its stakes by 78%, and now holds about 10 million shares. Another investment guru that also seems to feel quite bullish about this company is, the one and only, Warren Buffet, who has also invested about half a billion dollars in it. As we reported in a previous article, this is Mr. Buffett’s largest new position for Q1.

Renaissance Technologies is a New York-based hedge fund founded in 1982 by Jim Simons, a math Ph.D. One of his funds, the Medallion Fund is considered to be one of the most successful hedge funds in the industry, with returns so high that fees (fixed and performance-based) almost reach 50%.  Its portfolio is worth more than $41 billion, and comprises about 3,000 different stocks.

Disclosure: Javier Hasse holds no position in any stocks mentioned.

Recommended Reading:

Three Banks Stocks That Jim Simons and Insiders Like

Insider Purchases at Four Jim Simons’ Small and Micro-Cap Picks

Renaissance Technologies Loves These Stocks: McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO) & Others

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!